- (2021). Nuclear upregulation of class I phosphoinositide 3-kinase p110β correlates with high 47S rRNA levels in cancer cells. Journal of Cell Science. 1-13.
- (2021). Nuclear Phosphatidylinositol 3,4,5-Trisphosphate Interactome Uncovers an Enrichment in Nucleolar Proteins. Molecular & Cellular Proteomics. 18 pages.
- (2020). Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study. Immunity,Inflammation and Disease. 342-359.
- (2022). Two distinct biomarkers and their role in glioblastoma biological behavior.
Academic literature review
- (2021). Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy. Cancers.
- (2018). Class I Phosphoinositide 3-Kinase PIK3CA/p110α and PIK3CB/p110β Isoforms in Endometrial Cancer. International Journal of Molecular Sciences.